Efficacy of contrast-enhanced endoscopic ultrasonography for differentiation of non-Hodgkin lymphoma

Efficacy of contrast-enhanced endoscopic ultrasonography for differentiation of non-Hodgkin lymphoma - Contrast-enhanced endoscopic ultrasonography for non-Hodgkin lymphoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047907

Enrollment

Registered

2022-06-01

Start date

2016-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-Hodgkin lymphoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients who were undergo EUS-FNA and contrast-enhanced EUS in the mediastinal or abdominal lymphadenopathy and diagnosed non Hodgkin's based on pathology obtained by EUS-FNA

Exclusion criteria

Exclusion criteria: long axis of lymph nodes as evaluated by B-mode EUS were less than 10mm, patient with potential allergy of contrast agent material, pregnant women, and failure of other organs

Design outcomes

Primary

Measure	Time frame
Accuracy of qualitative evaluation of contrast-enhanced EUS in differentiating the malignancy of non-Hodgkin's lymphoma	—

Secondary

Measure	Time frame
Efficacy of quantitative evaluation using TIC of contrast-enhanced endoscopic ultrasonography in differentiating the malignancy of non-Hodgkin's lymphoma	—

Countries

Japan

Contacts

Public ContactKensaku Yoshida

Gifu Prefectural General Medical Center Gastroenterology

kensakuyoshidaky@gmail.com0582461111

Outcome results